Work

378: Tacrolimus, Sirolimus and Antithymocyte Globulin (rATG) for Graft Versus Host Disease Prophylaxis for Unrelated Donor Hematopoietic Cell Transplantation

Year: 2008

Type: article

Abstract: The effect of adding ATG to Tacrolimus/Sirolimus combination in graft-versus-host disease (GVHD) prophylaxis is largely unknown. We reviewed our records for patients who underwent unrelated transplants and received this combination for GVHD prophylaxis. Nineteen patients were identified who received their transplants between 8/06 and 02/07. Median age at time of transplant was 51.1 years (17–61.5). Nine recipients were males and 10 were females. The indications for transplant were as follows: ALL n = 9, AML n = 5, NHL n = 2, MDS n = 2 and CML n = 1.

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2007.12.388